Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1504 | 7543 | 36.9 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
389 | 3 | PEROXISOME//CARNITINE//JOURNAL OF INHERITED METABOLIC DISEASE | 30841 |
1504 | 2 | CARNITINE//L CARNITINE//TRIMETAZIDINE | 7543 |
973 | 1 | CARNITINE//L CARNITINE//CARNITINE DEFICIENCY | 2928 |
5486 | 1 | CARDIAC METABOLISM//PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423 | 1618 |
8921 | 1 | CARNITINE PALMITOYLTRANSFERASE//CARNITINE PALMITOYLTRANSFERASE I//CARNITINE PALMITOYLTRANSFERASE DEFICIENCY | 1204 |
15395 | 1 | TRIMETAZIDINE//PERHEXILINE//TRIMETAZIDINE MB | 715 |
18583 | 1 | RANOLAZINE//LATE SODIUM CURRENT//LATE I NA | 545 |
25236 | 1 | L CARNITINE DEHYDROGENASE//TRIMETHYLAMMONIUM COMPOUND//CROTONOBETAINE | 287 |
29850 | 1 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | 179 |
37064 | 1 | MALONIC ACIDURIA//MALONYL COA DECARBOXYLASE DEFICIENCY//MALONYL COA DECARBOXYLASE | 67 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARNITINE | authKW | 1219656 | 8% | 52% | 577 |
2 | L CARNITINE | authKW | 1004432 | 6% | 52% | 478 |
3 | TRIMETAZIDINE | authKW | 932177 | 4% | 79% | 290 |
4 | RANOLAZINE | authKW | 657683 | 3% | 80% | 204 |
5 | MILDRONATE | authKW | 212040 | 1% | 86% | 61 |
6 | CARNITINE PALMITOYLTRANSFERASE | authKW | 211416 | 1% | 54% | 97 |
7 | CARNITINE DEFICIENCY | authKW | 180452 | 1% | 63% | 71 |
8 | PROPIONYL L CARNITINE | authKW | 180060 | 1% | 78% | 57 |
9 | PERHEXILINE | authKW | 172512 | 1% | 84% | 51 |
10 | OCTN2 | authKW | 165375 | 1% | 74% | 55 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 18415 | 20% | 0% | 1525 |
2 | Nutrition & Dietetics | 3618 | 6% | 0% | 479 |
3 | Physiology | 3098 | 8% | 0% | 595 |
4 | Pharmacology & Pharmacy | 2834 | 14% | 0% | 1028 |
5 | Biochemistry & Molecular Biology | 2601 | 19% | 0% | 1456 |
6 | Peripheral Vascular Diseases | 2470 | 6% | 0% | 454 |
7 | Endocrinology & Metabolism | 1710 | 7% | 0% | 528 |
8 | Medicine, Research & Experimental | 1214 | 6% | 0% | 444 |
9 | Biophysics | 999 | 5% | 0% | 397 |
10 | Medical Laboratory Technology | 449 | 2% | 0% | 116 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HERITAGE MED 423 | 56991 | 0% | 78% | 18 |
2 | PROGRAM INTEGRAT CARDIAC METAB | 53145 | 0% | 77% | 17 |
3 | CARDIOVASC THER EUT AREA | 28480 | 0% | 54% | 13 |
4 | CARDIOELE OPHYSIOL | 26474 | 0% | 55% | 12 |
5 | TRANSIT IL 2020 | 20231 | 0% | 100% | 5 |
6 | INTERMEDIARY METAB | 16177 | 0% | 50% | 8 |
7 | CARDIOVASC GRP | 12764 | 1% | 6% | 56 |
8 | EQUIPE IDESH | 12139 | 0% | 100% | 3 |
9 | UNITE TRANSPLANTAT EXPT | 11761 | 0% | 36% | 8 |
10 | PREVENT MED NUTR | 11112 | 0% | 17% | 16 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASCULAR DRUGS AND THERAPY | 11315 | 1% | 4% | 74 |
2 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 10522 | 2% | 1% | 182 |
3 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 10014 | 2% | 2% | 128 |
4 | BIOCHEMICAL JOURNAL | 4706 | 3% | 1% | 190 |
5 | CARDIOVASCULAR RESEARCH | 4512 | 1% | 1% | 95 |
6 | RUSSIAN JOURNAL OF CARDIOLOGY | 3078 | 0% | 4% | 19 |
7 | JOURNAL OF INHERITED METABOLIC DISEASE | 2509 | 1% | 1% | 54 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2285 | 1% | 1% | 62 |
9 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 2189 | 0% | 2% | 32 |
10 | MOLECULAR GENETICS AND METABOLISM | 2001 | 1% | 1% | 40 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARNITINE | 1219656 | 8% | 52% | 577 | Search CARNITINE | Search CARNITINE |
2 | L CARNITINE | 1004432 | 6% | 52% | 478 | Search L+CARNITINE | Search L+CARNITINE |
3 | TRIMETAZIDINE | 932177 | 4% | 79% | 290 | Search TRIMETAZIDINE | Search TRIMETAZIDINE |
4 | RANOLAZINE | 657683 | 3% | 80% | 204 | Search RANOLAZINE | Search RANOLAZINE |
5 | MILDRONATE | 212040 | 1% | 86% | 61 | Search MILDRONATE | Search MILDRONATE |
6 | CARNITINE PALMITOYLTRANSFERASE | 211416 | 1% | 54% | 97 | Search CARNITINE+PALMITOYLTRANSFERASE | Search CARNITINE+PALMITOYLTRANSFERASE |
7 | CARNITINE DEFICIENCY | 180452 | 1% | 63% | 71 | Search CARNITINE+DEFICIENCY | Search CARNITINE+DEFICIENCY |
8 | PROPIONYL L CARNITINE | 180060 | 1% | 78% | 57 | Search PROPIONYL+L+CARNITINE | Search PROPIONYL+L+CARNITINE |
9 | PERHEXILINE | 172512 | 1% | 84% | 51 | Search PERHEXILINE | Search PERHEXILINE |
10 | OCTN2 | 165375 | 1% | 74% | 55 | Search OCTN2 | Search OCTN2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LOPASCHUK, GD , USSHER, JR , FOLMES, CDL , JASWAL, JS , STANLEY, WC , (2010) MYOCARDIAL FATTY ACID METABOLISM IN HEALTH AND DISEASE.PHYSIOLOGICAL REVIEWS. VOL. 90. ISSUE 1. P. 207 -258 | 277 | 46% | 421 |
2 | REUTER, SE , EVANS, AM , (2012) CARNITINE AND ACYLCARNITINES PHARMACOKINETIC, PHARMACOLOGICAL AND CLINICAL ASPECTS.CLINICAL PHARMACOKINETICS. VOL. 51. ISSUE 9. P. 553 -572 | 132 | 75% | 53 |
3 | STANLEY, WC , RECCHIA, FA , LOPASCHUK, GD , (2005) MYOCARDIAL SUBSTRATE METABOLISM IN THE NORMAL AND FAILING HEART.PHYSIOLOGICAL REVIEWS. VOL. 85. ISSUE 3. P. 1093 -1129 | 181 | 42% | 744 |
4 | TAEGTMEYER, H , YOUNG, ME , LOPASCHUK, GD , ABEL, ED , BRUNENGRABER, H , DARLEY-USMAR, V , DES ROSIERS, C , GERSZTEN, R , GLATZ, JF , GRIFFIN, JL , ET AL (2016) ASSESSING CARDIAC METABOLISM A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION.CIRCULATION RESEARCH. VOL. 118. ISSUE 10. P. 1659 -U485 | 240 | 37% | 3 |
5 | JASWAL, JS , KEUNG, W , WANG, W , USSHER, JR , LOPASCHUK, GD , (2011) TARGETING FATTY ACID AND CARBOHYDRATE OXIDATION - A NOVEL THERAPEUTIC INTERVENTION IN THE ISCHEMIC AND FAILING HEART.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1813. ISSUE 7. P. 1333 -1350 | 158 | 59% | 83 |
6 | ONAY-BESIKCI, A , OZKAN, SA , (2008) TRIMETAZIDINE REVISITED: A COMPREHENSIVE REVIEW OF THE PHARMACOLOGICAL EFFECTS AND ANALYTICAL TECHNIQUES FOR THE DETERMINATION OF TRIMETAZIDINE.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 2. P. 147-165 | 131 | 90% | 16 |
7 | RAMSAY, RR , GANDOUR, RD , VAN DER LEIJ, FR , (2001) MOLECULAR ENZYMOLOGY OF CARNITINE TRANSFER AND TRANSPORT.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY. VOL. 1546. ISSUE 1. P. 21 -43 | 134 | 80% | 198 |
8 | RINGSEIS, R , KELLER, J , EDER, K , (2012) ROLE OF CARNITINE IN THE REGULATION OF GLUCOSE HOMEOSTASIS AND INSULIN SENSITIVITY: EVIDENCE FROM IN VIVO AND IN VITRO STUDIES WITH CARNITINE SUPPLEMENTATION AND CARNITINE DEFICIENCY.EUROPEAN JOURNAL OF NUTRITION. VOL. 51. ISSUE 1. P. 1 -18 | 95 | 85% | 35 |
9 | GUARINI, G , HUQI, A , MORRONE, D , MARZILLI, M , (2016) PHARMACOLOGICAL AGENTS TARGETING MYOCARDIAL METABOLISM FOR THE MANAGEMENT OF CHRONIC STABLE ANGINA : AN UPDATE.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 30. ISSUE 4. P. 379 -391 | 98 | 85% | 0 |
10 | EVANS, AM , FORNASINI, G , (2003) PHARMACOKINETICS OF L-CARNITINE.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 11. P. 941-967 | 116 | 83% | 121 |
Classes with closest relation at Level 2 |